Cargando…

Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study

AIM: To investigate the association between blood lactate levels and metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus (T2DM). METHODS: 4628 Chinese T2DM patients were divided into quartiles according to blood lactate levels in this real-world study. Abdominal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yi-Lin, Ke, Jiang-Feng, Wang, Jun-Wei, Wang, Yu-Jie, Xu, Man-Rong, Li, Lian-Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200915/ https://www.ncbi.nlm.nih.gov/pubmed/37223022 http://dx.doi.org/10.3389/fendo.2023.1133991

Ejemplares similares

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
por: Wang, Jun-Wei, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology
por: Peng, Dandan, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
por: Xiao, Pei, et al.
Publicado: (2022)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
por: Maumus-Robert, Sandy, et al.
Publicado: (2023)

The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults
por: Li, Hejun, et al.
Publicado: (2022)

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes
por: Bayliss, Jacqueline, et al.
Publicado: (2021)

High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation
por: Decoin, Raphaël, et al.
Publicado: (2022)

Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
por: Liao, Yudi, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
por: Lee, Chang-Hoon, et al.
Publicado: (2021)

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver
por: López-Bermudo, Lucía, et al.
Publicado: (2022)

Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study
por: Liu, Jing, et al.
Publicado: (2022)

Association of circulating omentin level and metabolic-associated fatty liver disease: a systematic review and meta-analysis
por: Zhang, Qin, et al.
Publicado: (2023)

The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
por: Zhang, Xiaofu, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching
por: Zhu, Rong-Rong, et al.
Publicado: (2022)

The role of TRIM family in metabolic associated fatty liver disease
por: Zhang, Jingyue, et al.
Publicado: (2023)

The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease
por: Deng, Jiang, et al.
Publicado: (2021)

Non-linear association of fasting C-peptide and uric acid levels with renal dysfunction based on restricted cubic spline in patients with type 2 diabetes: A real-world study
por: Chen, Lu, et al.
Publicado: (2023)

Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study
por: Zhang, Zhi-Hui, et al.
Publicado: (2022)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

Corrigendum: Non-alcoholic fatty liver disease is associated with aortic calcification: a cohort study with propensity score matching
por: Zhu, Rong-Rong, et al.
Publicado: (2023)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Diet was less significant than physical activity in the prognosis of people with sarcopenia and metabolic dysfunction-associated fatty liver diseases: Analysis of the National Health and Nutrition Examination Survey III
por: Yi, Yun, et al.
Publicado: (2023)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents
por: Riekki, Hanna, et al.
Publicado: (2023)

Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
por: Song, Myeong Jun, et al.
Publicado: (2022)

Genetic polymorphisms of Ca(2+) transport proteins and molecular chaperones in mitochondria-associated endoplasmic reticulum membrane and non-alcoholic fatty liver disease
por: Tang, Zongzhe, et al.
Publicado: (2023)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease
por: Xing, Yuling, et al.
Publicado: (2023)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
por: Wang, Hongyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f2m0i5b0qetnj1bjqr4lr170kq